These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

816 related articles for article (PubMed ID: 20837696)

  • 1. Type I interferon: friend or foe?
    Trinchieri G
    J Exp Med; 2010 Sep; 207(10):2053-63. PubMed ID: 20837696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferon-λ: Immune Functions at Barrier Surfaces and Beyond.
    Lazear HM; Nice TJ; Diamond MS
    Immunity; 2015 Jul; 43(1):15-28. PubMed ID: 26200010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Roles of Type I Interferon in Bacterial Infection.
    Boxx GM; Cheng G
    Cell Host Microbe; 2016 Jun; 19(6):760-9. PubMed ID: 27281568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of gamma interferon in antimicrobial immunity.
    Shtrichman R; Samuel CE
    Curr Opin Microbiol; 2001 Jun; 4(3):251-9. PubMed ID: 11378475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crosstalk between Autophagy and Type I Interferon Responses in Innate Antiviral Immunity.
    Tian Y; Wang ML; Zhao J
    Viruses; 2019 Feb; 11(2):. PubMed ID: 30717138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beyond ISGlylation: Functions of Free Intracellular and Extracellular ISG15.
    Dos Santos PF; Mansur DS
    J Interferon Cytokine Res; 2017 Jun; 37(6):246-253. PubMed ID: 28467275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A critical link between Toll-like receptor 3 and type II interferon signaling pathways in antiviral innate immunity.
    Negishi H; Osawa T; Ogami K; Ouyang X; Sakaguchi S; Koshiba R; Yanai H; Seko Y; Shitara H; Bishop K; Yonekawa H; Tamura T; Kaisho T; Taya C; Taniguchi T; Honda K
    Proc Natl Acad Sci U S A; 2008 Dec; 105(51):20446-51. PubMed ID: 19074283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Type I interferon and bacterial infection].
    Diao R; Xu F; Wang XD
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2012 Jul; 41(4):464-8. PubMed ID: 22927085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beyond Good and Evil: Molecular Mechanisms of Type I and III IFN Functions.
    Dowling JW; Forero A
    J Immunol; 2022 Jan; 208(2):247-256. PubMed ID: 35017214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Triggering the innate antiviral response through IRF-3 activation.
    Hiscott J
    J Biol Chem; 2007 May; 282(21):15325-9. PubMed ID: 17395583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interferon signalling network in innate defence.
    Takaoka A; Yanai H
    Cell Microbiol; 2006 Jun; 8(6):907-22. PubMed ID: 16681834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Confounding roles for type I interferons during bacterial and viral pathogenesis.
    Carrero JA
    Int Immunol; 2013 Dec; 25(12):663-9. PubMed ID: 24158954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The protective role of endogenous interferon in viral, bacterial, and protozoal infections.
    Baron S; Weigent D; Stanton GJ; Peterson J
    Antiviral Res; 1985; Suppl 1():173-83. PubMed ID: 3936412
    [No Abstract]   [Full Text] [Related]  

  • 14. Microbial pathogenesis and type III interferons.
    Cohen TS; Parker D
    Cytokine Growth Factor Rev; 2016 Jun; 29():45-51. PubMed ID: 26987613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Principles of Effective and Robust Innate Immune Response to Viral Infections: A Multiplex Network Analysis.
    Huang Y; Dai H; Ke R
    Front Immunol; 2019; 10():1736. PubMed ID: 31396233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fueling Type I Interferonopathies: Regulation and Function of Type I Interferon Antiviral Responses.
    Ng CS; Kato H; Fujita T
    J Interferon Cytokine Res; 2019 Jul; 39(7):383-392. PubMed ID: 30897023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alpha and Beta Type 1 Interferon Signaling: Passage for Diverse Biologic Outcomes.
    Ng CT; Mendoza JL; Garcia KC; Oldstone MB
    Cell; 2016 Jan; 164(3):349-52. PubMed ID: 26824652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Type I IFN exhaustion is a host defence protecting against secondary bacterial infections.
    Furuya Y; Müllbacher A
    Scand J Immunol; 2013 Nov; 78(5):395-400. PubMed ID: 24006947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Type I Interferon and the Spectrum of Susceptibility to Viral Infection and Autoimmune Disease: A Shared Genomic Signature.
    Sugrue JA; Bourke NM; O'Farrelly C
    Front Immunol; 2021; 12():757249. PubMed ID: 34917078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytokine synergy: an underappreciated contributor to innate anti-viral immunity.
    Bartee E; McFadden G
    Cytokine; 2013 Sep; 63(3):237-40. PubMed ID: 23693158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.